Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

33
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
33
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

53
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
53
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

51
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
51
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.5K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  3. 研究分野
  5. 生物医学と臨床科学
  7. 心血管医学と血液学
  9. 心臓病 (心血管疾患を含む)
  11. 自動心電図報告における左心房高縮と死亡リスク

自動心電図報告における左心房高縮と死亡リスク

Gabriela Miana Paixão1, Nathalia Coelho de Castro Nunes1, Milena Soriano Marcolino1

  • 1Telehealth Center, Hospital das Clínicas, Universidade Federal de Minas Gerais,Belo Horizonte, Brazil; Departament of Internal Medicine, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Journal of electrocardiology
|September 5, 2025

関連する実験動画

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
06:34

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography

Published on: October 28, 2020

4.1K
In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
08:13

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography

Published on: February 16, 2016

19.7K
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

308

PubMed で要約を見る

まとめ
この要約は機械生成です。

ECGのグラスゴースコアは,死亡率を予測することができます. プライマリケア患者におけるLVH- グラスゴウスコアの上昇は,あらゆる原因による死亡のリスクの増加と関連していました.

科学分野:

  • 心臓病科
  • デジタル・ヘルス
  • 公衆衛生

背景:

  • 左心室縮 (LVH) は心筋回路図で検出可能な変化を引き起こすが,現在の基準では心声回路図と比較して感度が低い.
  • 自動化されたEKG分析は大規模な可能性を秘めているが,自動的に検出されたLVHの予後値に関する研究は限られている.

研究 の 目的:

  • グラスゴー・プログラムのECGによるLVHスコアと,ブラジルのプライマリケア集団における全死亡率との関連を評価する.
  • 自動化された心電図による LVH が死亡率の予測因子であるかどうかを判断する.

主な方法:

  • 18歳以上の患者におけるCODEコホート (2010年−2017年) のデジタルECGの分析
  • グラスゴー大学の自動ECG解釈プログラムを使用して,LVHスコア (確定≥6. 3 確率5. 0- 6. 3 確率4. 0- 5. 0) を測定した.
  • コックス回帰分析は,年齢,性別,併発性により調整され,LVHスコアと死亡率の関係を評価した.

主要な成果:

  • この研究には130万人以上の患者が含まれており,異常なLVH-グラスゴースコア (≥4. 0) の流行率は18. 5%でした.
  • 追跡期間の中央値は3. 47年,全因死亡率は2. 68%でした.
  • 確固たるLVH (HR1. 64) と確固たるLVH (HR1.18) は,全体的な死亡率のリスクが著しく高く,LVHもリスク増加に関連している可能性がある (HR1. 09).
キーワード:
エレクトロカーディオグラム電子コホート左心室の縮死亡率

関連する実験動画

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
06:34

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography

Published on: October 28, 2020

4.1K
In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
08:13

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography

Published on: February 16, 2016

19.7K
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

308

結論:

  • 自動化されたECG分析から得られたLVH-グラスゴウスコアは,貴重な予後ツールとして機能します.
  • 高いLVH-グラスゴースコアは,このプライマリケアコホートにおける全因死亡率の増加と独立して関連しています.